GW3965 upregulated the expression of the known LXR target genes ABCA1 and ABCG1 in COPD alveolar macrophages, confirming the pharmacological activity of this drug on these cells. The gene discussed is ABCA1; the disease is chronic obstructive pulmonary disease.